IP Library Granted Patent US 8,657,787
Granted Patent B2
US 8,657,787 · App. 12/444,162 · Granted Feb 25, 2014

Injector having low input power

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,657,787
App. No.
12/444,162
Granted
Feb 25, 2014
Kind
B2
Abstract

A powered injector that stores energy at a low rate when not in use and delivers energy at a high rate during injection. Energy may be stored in a highly responsive energy storage device, such as a capacitor, for rapid delivery of power to the injector motor. In certain embodiments, wires connecting the powered injector to a power supply may be relatively small and inexpensive because the current and voltage loads placed on the wires are relatively low.

Claims (36)

1. A powered injector for injecting medical fluid, the powered injector comprising:

a single, on-board energy storage device that comprises:

a power input having an input current carrying capacity; and

a power output having an output current carrying capacity, wherein the output current carrying capacity is greater than the input current carrying capacity such that the power input is at a low rate and the power output is at a high rate;

a motor coupled to the power output of the single, on-board energy storage device; and

a ram coupled to the motor and having a syringe plunger interface.

2. The powered injector of claim 1 , wherein the single, on-board energy storage device comprises one or more capacitors.

3. The powered injector of claim 2 , wherein the one or more capacitors have a series capacitance greater than about 30 farads.

4. The powered injector of claim 2 , wherein the one or more capacitors comprises a series of serially connected supercapacitors, wherein one end of the series of supercapacitors is coupled to the input of the single, on-board energy storage device, and wherein another end of the series of supercapacitors is coupled to the output of the single, on-board energy storage device.

5. The powered injector of claim 1 , further comprising:

a power cable connected to the input of the single, on-board energy storage device; and

a power source external to the powered injector and connected to the input of the single, on-board energy storage device via the power cable.

6. The powered injector of claim 5 , wherein a substantial portion of a length of the power cable consists essentially of insulated wire having a conductive portion with a cross-sectional area of less than about 2.6×10 −3 square inch.

7. The powered injector of claim 5 , wherein the single, on-board energy storage device is coupled to the power source via both the power cable and protection circuitry.

8. The powered injector of claim 5 , wherein the power source is a power source of less than about 500 watts.

9. The powered injector of claim 6 , wherein the single, on-board energy storage device is configured to output more than about 1000 watts of power when the single, on-board energy storage device is in an energized state.

10. The powered injector of claim 1 , further comprising:

a syringe having a medical fluid therein, wherein the syringe is coupled to the syringe plunger interface of the ram.

11. The powered injector of claim 1 , wherein the power input is the only power input into the single, on-board energy storage device.

12. An electric injector for use with a syringe having medical fluid therein, the injector comprising:

a single, on-board energy storage device comprising a plurality of supercapacitors coupled to one another in series;

a motor coupled in parallel to the plurality of supercapacitors; and

a syringe interface coupled to the motor.

13. The injector of claim 12 , wherein the plurality of supercapacitors have a combined capacitance greater than about one thousand farads.

14. The injector of claim 12 , wherein the plurality of supercapacitors comprises more than four supercapacitors.

15. The injector of claim 12 , further comprising:

a conductor having a current carrying capacity greater than about 10 amps, wherein the motor is connected to the plurality of supercapacitors through the conductor.

16. The injector of claim 12 , further comprising:

a controller having a switch configured to transmit more than about 800 watts of power when in a closed state, wherein the switch is disposed in series between the plurality of supercapacitors and the motor.

17. A method of medical fluid injector operation, the method comprising:

receiving energy from a remote power supply at an input wattage;

storing the energy on board the medical fluid injector; and

outputting at least a portion of the energy to a motor at an output wattage, wherein the output wattage is at least twice as great as the input wattage.

18. The method of claim 17 , wherein the storing comprises charging a bank of capacitors having a capacitance greater than about 1 farad.

19. The method of claim 17 , wherein the output wattage is greater than about 500 watts.

20. The method of claim 17 , wherein the outputting comprises moving a ram of the injector.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2009
From: NEER, CHARLES S.
To: MALLINCKRODT INC.
Reel/Frame 022498/0941 →